Jefferies Group’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-14,700
Closed -$1.18M 2870
2016
Q4
$1.18M Sell
14,700
-248,289
-94% -$19.7M 0.01% 1181
2016
Q3
$21M Buy
+262,989
New +$21.2M 0.11% 150
2016
Q2
Sell
-59,994
Closed -$3.3M 2643
2016
Q1
$3.3M Buy
59,994
+32,550
+119% +$1.77M 0.02% 642
2015
Q4
$1.7M Sell
27,444
-25,017
-48% -$1.58M 0.01% 942
2015
Q3
$3.31M Buy
52,461
+52,311
+34,874% +$3.73M 0.02% 670
2015
Q2
$11K Sell
150
-18,477
-99% -$1.33M ﹤0.01% 2798
2015
Q1
$1.22M Sell
18,627
-923
-5% -$61.4K 0.01% 957
2014
Q4
$1.27M Buy
19,550
+15,009
+331% +$967K 0.01% 882
2014
Q3
$273K Buy
4,541
+1,321
+41% +$86.3K ﹤0.01% 1666
2014
Q2
$223K Sell
3,220
-32,322
-91% -$2.1M ﹤0.01% 1698
2014
Q1
$2.32M Buy
35,542
+18,112
+104% +$1.18M 0.02% 559
2013
Q4
$1.08M Buy
+17,430
New +$1.01M 0.01% 794

Other funds holding STJ

Jefferies Group's STJ Position: Q1 2017 in Review

Jefferies Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 14,700 shares — an estimated $1.18M sold.

Jefferies Group first reported a position in STJ in Q4 2013 and held it in 12 quarters. The position peaked at $21M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Jefferies Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Jefferies Group sold 14,700 St Jude Medical shares in Q1 2017, an estimated $1.18M.
  • Jefferies Group first reported a position in St Jude Medical in Q4 2013 and held it in 12 quarters.
  • Jefferies Group's St Jude Medical position peaked at $21M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Jefferies Group's 13F filing for Q1 2017, filed 15 May 2017.